Sofosbuvir/ledipasvir improved patient-reported outcomes in HCV

BOSTON - A hepatitis C treatment regimen of sofosbuvir and ledipasvir without ribavirin is associated with significant improvement in patient-reported outcomes, new research suggests.
<br...